Total Payments
$6,626
2021 Payments
$119.06
Companies
39
Transactions
545
Medicare Patients
575
Medicare Billing
$30,284
Payment Breakdown by Category
Food & Beverage$6,535 (98.6%)
Education$90.80 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,535 | 534 | 98.6% |
| Education | $90.80 | 11 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $999.52 | 101 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $854.72 | 40 | $0 (2021) |
| Novo Nordisk Inc | $703.26 | 66 | $0 (2021) |
| Amgen Inc. | $581.59 | 40 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $447.36 | 36 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $354.70 | 36 | $0 (2020) |
| Amarin Pharma Inc. | $306.62 | 25 | $0 (2021) |
| GlaxoSmithKline, LLC. | $267.30 | 22 | $0 (2019) |
| Daiichi Sankyo Inc. | $243.78 | 11 | $0 (2018) |
| Allergan, Inc. | $224.35 | 30 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $119.06 | 9 | Amarin Pharma Inc. ($29.30) |
| 2020 | $777.45 | 56 | Amarin Pharma Inc. ($225.20) |
| 2019 | $1,445 | 108 | PFIZER INC. ($294.39) |
| 2018 | $1,351 | 112 | PFIZER INC. ($348.64) |
| 2017 | $2,933 | 260 | PFIZER INC. ($356.49) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular | ||||||
| 01/27/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Respiratory | ||||||
| 01/26/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.71 | General |
| Category: Cardiovascular | ||||||
| 01/25/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neuroscience | ||||||
| 01/21/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/15/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular | ||||||
| 01/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes | ||||||
| 01/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/07/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: Neurology | ||||||
| 12/22/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 12/18/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Inflammation | ||||||
| 12/14/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Cardiovascular | ||||||
| 12/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Bone Health | ||||||
| 12/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Cardiovascular | ||||||
| 11/19/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Cardiovascular | ||||||
| 11/11/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.92 | General |
| Category: Cardiovascular | ||||||
| 11/11/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Bone Health | ||||||
| 11/05/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Cardiovascular | ||||||
| 11/03/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 10/21/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Cardiovascular | ||||||
| 10/16/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 50 | 50 | $4,658 | $582.91 |
| 2020 | 16 | 525 | 755 | $76,231 | $29,701 |
Total Patients
575
Total Services
805
Medicare Billing
$30,284
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 22 | 22 | $682.00 | $407.22 | 59.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $2,520 | $175.69 | 7.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,456 | $0 | — |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 142 | $23,856 | $5,694 | 23.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 108 | 150 | $16,800 | $4,434 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 35 | 35 | $5,775 | $4,057 | 70.2% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 17 | 17 | $3,910 | $3,827 | 97.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 16 | 17 | $4,811 | $2,281 | 47.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 43 | 44 | $2,068 | $2,065 | 99.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 11 | 11 | $2,750 | $1,889 | 68.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 12 | 12 | $1,392 | $1,384 | 99.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 43 | 44 | $2,024 | $728.53 | 36.0% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 19 | 93 | $2,046 | $694.17 | 33.9% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 15 | 15 | $4,830 | $588.33 | 12.2% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 14 | 14 | $1,862 | $557.33 | 29.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 30 | 30 | $1,380 | $495.09 | 35.9% |
| 85610 | Blood test, clotting time | Office | 2020 | 14 | 92 | $1,012 | $391.53 | 38.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 17 | 17 | $527.00 | $309.91 | 58.8% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 19 | 22 | $1,188 | $305.42 | 25.7% |
About Dr. James Tarwater, D.O
Dr. James Tarwater, D.O is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548267545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Tarwater, D.O has received a total of $6,626 in payments from pharmaceutical and medical device companies, with $119.06 received in 2021. These payments were reported across 545 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,535).
As a Medicare-enrolled provider, Tarwater has provided services to 575 Medicare beneficiaries, totaling 805 services with total Medicare billing of $30,284. Data is available for 2 years (2020–2021), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 07/05/2005
- Last Updated 09/26/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548267545
Products in Payments
- FARXIGA (Drug) $426.93
- Victoza (Drug) $378.28
- CHANTIX (Drug) $338.91
- Vascepa (Drug) $306.62
- Prolia (Biological) $279.56
- XARELTO (Drug) $267.69
- Movantik (Drug) $230.25
- SYMBICORT (Drug) $215.20
- LYRICA (Drug) $190.47
- BEVESPI AEROSPHERE (Drug) $188.51
- VIAGRA (Drug) $182.10
- Ozempic (Drug) $172.12
- PREVNAR - 13 (Biological) $169.51
- JARDIANCE (Drug) $158.60
- ENTRESTO (Drug) $146.09
- Aimovig (Biological) $127.81
- TOUJEO (Drug) $116.10
- Tresiba (Drug) $115.97
- BREO (Drug) $115.78
- JANUVIA (Drug) $115.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Family Medicine $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Family Medicine $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Family Medicine $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Family Medicine $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Family Medicine $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051
Family Medicine $19,051